| [1] |
H.F. Escobar-Morreale. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol, 14 (5) ( 2018), pp. 270-284 DOI: 10.1038/nrendo.2018.24
|
| [2] |
R. Li, Q. Zhang, D. Yang, S. Li, S. Lu, X. Wu, et al.. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod, 28 (9) ( 2013), pp. 2562-2569 DOI: 10.1093/humrep/det262
|
| [3] |
R. Yang, Q. Li, Z. Zhou, W. Qian, J. Zhang, Z. Wu, et al.. Changes in the prevalence of polycystic ovary syndrome in China over the past decade. Lancet Reg Health West Pac, 25 ( 2022), Article 100494
|
| [4] |
L. Wang, B. Zhou, Z. Zhao, L. Yang, M. Zhang, Y. Jiang, et al.. Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004-18. Lancet, 398 (10294) ( 2021), pp. 53-63 DOI: 10.1117/12.2602446
|
| [5] |
R. Azziz, E. Carmina, Z. Chen, A. Dunaif, J.S.E. Laven, R.S. Legro, et al.. Polycystic ovary syndrome. Nat Rev Dis Primers, 2 ( 2016), p. 16057
|
| [6] |
M. Andersen, D. Glintborg. Diagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT?. Eur J Endocrinol, 179 (3) ( 2018), Article D1-14
|
| [7] |
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19(1):41-7.
|
| [8] |
Q. Wang. Reconsideration of the three key scientific issues of TCM constitution and its prospect: speech at the 19th academic annual meeting of the TCM Constitution Branch, China Association of Chinese Medicine. J Beijing Univ Tradit Chin Med, 44 (12) ( 2021), pp. 1061-1066 [Chinese].
|
| [9] |
L. Li, H. Yao, J. Wang, Y. Li, Q. Wang. The role of Chinese medicine in health maintenance and disease prevention: application of Constitution Theory. Am J Chin Med, 47 (3) ( 2019), pp. 495-506 DOI: 10.1142/s0192415x19500253
|
| [10] |
J. Wang, Q. Wang, L. Li, Y. Li, H. Zhang, L. Zheng, et al.. Phlegm-dampness constitution: genomics, susceptibility, adjustment and treatment with traditional Chinese medicine. Am J Chin Med, 41 (2) ( 2013), pp. 253-262
|
| [11] |
Wang Y, Liu X, Xie L, Gao J, Ma H, Wang X, et al. Analysis of baseline characteristics of different TCM syndromes in infertile patients with polycystic ovary syndrome. China J Tradit Chin Med Pharm 2021; 36(7):4318-24. Chinese.
|
| [12] |
X. Xu, J. Hall, J. Byles, Z. Shi. Dietary pattern is associated with obesity in older people in China: data from China Health and Nutrition Survey (CHNS). Nutrients, 7 (9) ( 2015), pp. 8170-8188 DOI: 10.3390/nu7095386
|
| [13] |
X. Wang, J. Wang, L. Li, Y. Zheng, M. Bai, Y. Li, et al.. Evaluation of interventive effect of WANG Qi’s “Phlegm-dampness Constitution Conditioning Formula” in treating phlegm-dampness constitution. Tianjin J Tradit Chin Med, 36 (4) ( 2019), pp. 319-321 [Chinese]
|
| [14] |
X. Wu, C.C. Wang, Y. Cao, J. Li, Z. Li, H. Ma, et al.. Novel genetic risk and metabolic signatures of insulin signaling and androgenesis in the anovulation of polycystic ovary syndrome. Engineering, 23 (4) ( 2023), pp. 103-111
|
| [15] |
X. Wu, E. Stener-Victorin, H. Kuang, H. Ma, J. Gao, L. Xie, et al.. Effect of acupuncture and clomiphene in Chinese women with polycystic ovary syndrome: a randomized clinical trial. JAMA, 317 (24) ( 2017), pp. 2502-2514 DOI: 10.1001/jama.2017.7217
|
PDF(265 KB)
